Pharmacological Evaluation of F45 on the Cardiovascular System Using In Vitro, In Vivo Models and Molecular Dockings

Authors

  • Ikbolkhon Abdurazakova Fergana Medical Institute of Public Health, Fergana Region, Uzbekistan
  • Anvar Zaynabiddinov Andijan State University, Andijan Region, Uzbekistan
  • Izzatullo Abdullaev A. S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Plant Cytoprotectors Laboratory and Pharamacology, Tashkent, Uzbekistan
  • Lazizbek Makhmudov A. S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Plant Cytoprotectors Laboratory and Pharamacology, Tashkent, Uzbekistan
  • Ulugbek Gayibov A. S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Plant Cytoprotectors Laboratory and Pharamacology, Tashkent, Uzbekistan
  • Sirojiddin Omonturdiev A. S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Plant Cytoprotectors Laboratory and Pharamacology, Tashkent, Uzbekistan
  • Gafurjon Abdullayev Namangan State University, Namangan Region, Uzbekistan
  • Madina Xolmirzayeva Andijan State University, Andijan Region, Uzbekistan
  • Sherzod Zhurakulov Institute of the Chemistry of Plant Substances, Uzbekistan Academy of Sciences, Tashkent, Uzbekistan

DOI:

https://doi.org/10.48048/tis.2025.10924

Keywords:

F45, Vasorelaxation, Calcium channels, Molecular docking, Tail-cuff

Abstract

The current study investigated the vasorelaxant and antihypertensive potential of the novel compound F-45 through a combination of in vitro, in vivo, and in silico approaches. F-45 demonstrated significant relaxation of rat aortic rings pre-contracted with KCl and phenylephrine, suggesting its capacity to inhibit both voltage-dependent L-type Ca2+ channels and receptor-operated calcium entry mechanisms. At 70 μM, F-45 reduced KCl-induced contraction by 84.0% ± 1.3%, while 45 μM of F-45 inhibited phenylephrine-induced contraction by 78.0% ± 2.2%. Endothelium-denuded experiments confirmed that nitric oxide signaling contributes significantly to F-45-mediated vasorelaxation, with a 35.0% ± 2.4% reduction in relaxation observed after endothelial removal. Molecular docking studies revealed high binding affinities of F-45 for Ca2+-ATPase (−8.6 kcal/mol) and Sodium\Calcium Exchanger (−6.8 kcal/mol), supporting its role in modulating calcium transport. In vivo experiments using tail-cuff plethysmography showed that 50 mg/kg of F-45 reduced SBP and DBP from 132.5 ± 12.3 and 94.3 ± 9.1 to 96.8 ± 9.4 and 65.3 ± 6.4 mmHg, respectively. In the adrenaline-induced hypertension model, F-45 decreased elevated SBP and DBP from 140.8 ± 14.2 and 104.3 ± 10.3 to 90.0 ± 8.7 and 61.5 ± 6.0 mmHg within 2 h. These findings suggested that F-45 is a promising candidate for further development as a natural antihypertensive agent with multimodal action.

HIGHLIGHTS

  • F45 demonstrated potent vasorelaxant activity in isolated rat aortic rings, primarily through inhibition of L-type and receptor-operated calcium channels.
  • Endothelium-dependent mechanisms, especially nitric oxide (NO) signaling, significantly contributed to the vascular relaxation induced by F-45.
  • Molecular docking analysis revealed high binding affinities of F-45 to Ca2+-ATPase (−8.6 kcal/mol) and NCX (−6.8 kcal/mol), supporting its role in calcium homeostasis modulation.
  • In vivo experiments confirmed a dose-dependent antihypertensive effect, with 50 mg/kg of F-45 significantly reducing systolic and diastolic blood pressure.
  • In an adrenaline-induced hypertension model, F-45 rapidly normalized elevated blood pressure, suggesting its potential as a fast-acting antihypertensive agent.

GRAPHICAL ABSTRACT

Downloads

Download data is not yet available.

References

M Di Cesare, P Perel, S Taylor, C Kabudula, H Bixby, TA Gaziano, DV McGhie, J Mwangi, B Perva, J Narula, D Pineiro and FJ Pinto. The heart of the world. Global Heart 2024; 19(1), 11.

I Abdullaev, U Gayibov, S Omonturdiev, S Fotima, S Gayibova and T Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic target. The Journal of Biomedical Research 2025; 39(3), 254-269.

CJ Hutchings, P Colussi and TG Clark. Ion channels as therapeutic antibody targets. mAbs 2019; 11(2), 265-296.

AA Abdullaev, DR Inamjanov, DS Abduazimova, SZ Omonturdiyev, UG Gayibov, SN Gayibova and TF Aripov. Sílybum Mariánum’s impact on physiological alterations and oxidative stress in diabetic rats. Biomedical and Pharmacology Journal 2024; 17(2), 1291-1300.

BK Joseph, KM Thakali, CL Moore and SW Rhee. Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches. Pharmacological Research 2013; 70(1), 126-138.

O Gaibullayeva, A Islomov, D Abdugafurova, B Elmurodov, B Mirsalixov, L Mahmudov, I Adullaev, K Baratov, S Omonturdiev and S Sa’dullayeva. Inula helenium L. root extract in sunflower oil: Determination of its content of water-soluble vitamins and immunity-promoting effect. Biomedical and Pharmacology Journal 2024; 17(4), 2729-2737.

AQQ Azimova, AX Islomov, SA Maulyanov, DG Abdugafurova, LU Mahmudov, IZ Abdullaev, AS Ishmuratova, SQ Siddikova and IR Askarov. Determination of vitamins and pharmacological properties of Vitis vinifera L. plant fruit part (mixed varieties) syrup-honey. Biomedical and Pharmacology Journal 2024; 17(4), 2779-2786.

AV Mahmudov, OS Abduraimov, SB Erdonov, UG Gayibov and LY Izotova. Bioecological features of Nigella sativa L. in different conditions of Uzbekistan. Plant Science Today 2022; 9(2), 421-426.

OS Zoirovich, AIZ Ugli, ID Raxmatillayevich, ML Umarjonovich, ZM Ravshanovna and G Sabina. The effect of Ájuga Turkestánica on the rat aortic smooth muscle ion channels. Biomedical and Pharmacology Journal 2024; 17(2), 1213-1222.

D Inomjonov, I Abdullaev, S Omonturdiev, A Abdullaev, L Maxmudov, M Zaripova, M Abdullayeva, D Abduazimova, S Menglieva, S Gayibova, M Sadbarxon, U Gayibov and T Aripov. In vitro and In vivo studies of Crategus and Inula helenium extracts: Their effects on rat blood pressure. Trends in Sciences 2025; 22(3), 9158.

A Abdullaev, I Abdullaev, A Bogbekov, U Gayibov, S Omonturdiev, S Gayibova, M Turahodjayev, K Ruziboev and T Aripov. Antioxidant potential of Rhodiola heterodonta extract: Activation of Nrf2 pathway via integrative in vivo and in silico studies. Trends in Sciences 2025; 22(5), 9521.

HM Berman, J Westbrook, Z Feng, G Gilliland, TN Bhat, H Weissig, IN Shindyalov and PE Bourne. The protein data bank. Nucleic Acids Research 2000; 28(1), 235-242.

H Zohny, J McMillan and M King. Ethics of generative AI. Journal of Medical Ethics 2023; 49(2), 79-80.

M Iman, A Saadabadi and A Davood. Molecular docking analysis and molecular dynamics simulation study of ameltolide analogous as a sodium channel blocker. Turkish Journal of Chemistry 2015; 39(2), 10.

J Palacios, D Asunción-Alvarez, D Aravena, M Chiong, MA Catalán, C Parra, F Cifuentes and A Paredes. A new oxime synthesized from Senecio nutans SCh. Bip (chachacoma) reduces calcium influx in the vascular contractile response in rat aorta. RSC Advances 2024; 14, 9933-9942.

J Striessnig, NJ Ortner and A Pinggera. Pharmacology of L-type calcium channels: Novel drugs for old targets? Current Molecular Pharmacology 2015; 8(2), 110-122.

M Al-Khrasani, DA Karadi, AR Galambos, B Sperlagh and ES Vizi. The pharmacological effects of phenylephrine are indirect, mediated by noradrenaline release from the cytoplasm. Neurochemical Research 2022; 47(11), 3272-3284.

UG Gayibov, SN Gayibova, DS Abduazimova, RN Rakhimov, HS Ruziboev, MA Xolmirzayeva, AE Zaynabiddinov and TF Aripov. Antioxidant and cardioprotective properties of polyphenolic plant extract of Rhus glabra L. Plant Science Today 2024; 11(3), 2348-1900.

TF Aripov and UG Gayibov. Antiradical and antioxidant activity of the preparation “Rutan” from Rhus coriaria L. Journal of Theoretical and Clinical Medicine 2023; 4, 164-170.

AV Mahmudov, OS Abduraimov, SB Erdonov, AL Allamurotov, OT Mamatkasimov, UG Gayibov and LY Izotova. Seed productivity of Linum usitatissimum L. in different ecological conditions of Uzbekistan. Plant Science Today 2022; 9(4), 1090-1101.

A Sandoo, JJCSV van Zanten, GS Metsios, D Carroll and GD Kitas. The endothelium and its role in regulating vascular tone. The Open Cardiovascular Medicine Journal 2010; 23(4), 302-312.

PJ Tonge. Drug-target kinetics in drug discovery. ACS Chemical Neuroscience Journal 2018; 9(1), 29-39.

S Sodiqova, S Kadirova, A Zaynabiddinov, I Abdullaev, L Makhmudov, U Gayibov, M Yuldasheva, M Xolmirzayeva, R Rakhimov, A Mutalibov and H Karimjonov. Channelopathy activity of A-41(Propyl ester of gallic acid): Experimental and computational study of antihypertensive activity. Trends in Sciences 2025 22(9), 10496.

M Zaripova, I Abdullaev, A Bogbekov, U Gayibov, S Omonturdiev, R Makhmudov, N Ergashev, G Jabbarova, S Gayibova and T Aripov, T. In vitro and in silico studies of Gnaphalium U. extract: Inhibition of α-amylase and α-glucosidase as a potential strategy for metabolic syndrome regulation. Trends in Sciences 2025 22(8), 10098.

UG Gayibov, EJ Komilov, RN Rakhimov, NA Ergashev, NG Abdullajanova, MI Asrorov and TF Aripov. Influence of new polyphenol compound from Euphorbia plant on mitochondrial function. Journal of Microbiology Biotechnology and Food Science 2019; 8(4), 1021-1025.

S Shao and RS Hegde. Membrane protein insertion at the endoplasmic reticulum. Annual Review of Cell and Developmental Biology 2011; 27, 25-56.

EM Capes, R Loaiza and HH Valdivia. Ryanodine receptors. Skelet Muscle 2011; 1(1), 18.

Y Umidakhon, B Erkin, G Ulugbek, N Bahadir and A Karim. Correction of the mitochondrial NADH oxidase activity, peroxidation and phospholipid metabolism by haplogenin-7-glucoside in hypoxia and ischemia. Trends in Sciences 2022; 19(21), 6260.

MK Pozilov, U Gayibov, MI Asrarov, NG Abdulladjanova, HS Ruziboev and TF Aripov. Physiological alterations of mitochondria under diabetes condition and its correction by polyphenol gossitan. Journal of Microbiology Biotechnology and Food Science 2022; 12(2), e2224.

AG Vakhobjonovna, KE Jurayevich, AIZ Ogli, EN Azamovich, MR Rasuljonovich and AM Islomovich. Tannins as modulators in the prevention of mitochondrial dysfunction. Trends in Sciences 2025 22(8), 10436.

Z Shakiryanova, R Khegay, U Gayibov, A Saparbekova, Z Konarbayeva, A Latif and O Smirnova. Isolation and study of a bioactive extract enriched with anthocyanin from red grape pomace (Cabernet Sauvignon). Agronomy Research 2023; 21(3), 1293-1303.

U Gayibov, SN Gayibova, KP Ma’murjon, FS Tuxtaeva, UR Yusupova, GMK Djabbarova, ZA Mamatova, NA Ergashev and TF Aripov. Influence of quercetin and dihydroquercetin on some functional parameters of rat liver mitochondria. Journal of Microbiology, Biotechnology and Food Sciences 2021; 11(1), e2924.

DG Harrison, M Bader, LO Lerman, G Fink, SA Karumanchi, JF Reckelhoff, MLS Sequeira-Lopez and RM Touyz. Tail-cuff versus radiotelemetry to measure blood pressure in mice and rats. Hypertension 2024; 81(1), 3-5.

MR Zaripova, SN Gayibova, RR Makhmudov, AA Mamadrahimov, NL Vypova, UG Gayibov, SM Miralimova and TF Aripov. Characterization of Rhodiola heterodonta (Crassulaceae): Phytocomposition, antioxidant and antihyperglycemic activities. Preventitive Nutrition Food Science 2024; 29(2), 135-145.

Downloads

Published

2025-09-10

Most read articles by the same author(s)

1 2 > >>